Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Godelieve J de Bree

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|December 2, 2021
[SARS-CoV-2 neutralizing monoclonal antibodies: a potential breakthrough in the early treatment of Covid-19 in high-risk patients]Godelieve J de Bree, W Joost Wiersinga
Current Opinion in Infectious Diseases|December 15, 2015
B cells in HIV pathogenesisGodelieve J de Bree, Rebecca M Lynch
The Lancet. HIV|April 20, 2019
Broadly neutralising antibodies in post-treatment controlGodelieve J de Bree, Rogier W Sanders
Current Opinion in HIV and AIDS|May 15, 2026
Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment controlDita C Bolluyt, Godelieve J de Bree, Alexander O Pasternak
The Lancet. HIV|January 2, 2018
Wild-type HIV infection despite PrEP: a lot to learn from a case report - Authors' replyElske Hoornenborg, Maria Prins, Jan M Prins, et al.
Journal of Clinical Immunology|May 26, 2018
Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient PatientEster M van Leeuwen, Eloy Cuadrado, Anke M Gerrits, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 15, 2021
[Lymphadenopathy in general practice]Jarom Heijmans, Sarah Krausz, Judy M van Es, et al.
International Journal of Molecular Sciences|March 27, 2025
Synergistic Activity of Second Mitochondrial-Derived Activator of Caspases Mimetic with Toll-like Receptor 8 Agonist Reverses HIV-1-Latency and Enhances Antiviral ImmunityKillian E Vlaming, Jade Jansen, Godelieve J de Bree, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 8, 2020
[HIV vaccine: how far along are we?]Emma I M M Reiss, Marit J van Gils, Rogier W Sanders, et al.
Plos One|November 11, 2016
The Financial Burden of Non-Communicable Chronic Diseases in Rural Nigeria: Wealth and Gender Heterogeneity in Health Care Utilization and Health ExpendituresWendy Janssens, Jann Goedecke, Godelieve J de Bree, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Nederlands Tijdschrift Voor Geneeskunde|December 2, 2021
[SARS-CoV-2 neutralizing monoclonal antibodies: a potential breakthrough in the early treatment of Covid-19 in high-risk patients]Godelieve J de Bree, W Joost Wiersinga
Current Opinion in Infectious Diseases|December 15, 2015
B cells in HIV pathogenesisGodelieve J de Bree, Rebecca M Lynch
The Lancet. HIV|April 20, 2019
Broadly neutralising antibodies in post-treatment controlGodelieve J de Bree, Rogier W Sanders
Current Opinion in HIV and AIDS|May 15, 2026
Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment controlDita C Bolluyt, Godelieve J de Bree, Alexander O Pasternak
The Lancet. HIV|January 2, 2018
Wild-type HIV infection despite PrEP: a lot to learn from a case report - Authors' replyElske Hoornenborg, Maria Prins, Jan M Prins, et al.
Journal of Clinical Immunology|May 26, 2018
Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient PatientEster M van Leeuwen, Eloy Cuadrado, Anke M Gerrits, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 15, 2021
[Lymphadenopathy in general practice]Jarom Heijmans, Sarah Krausz, Judy M van Es, et al.
International Journal of Molecular Sciences|March 27, 2025
Synergistic Activity of Second Mitochondrial-Derived Activator of Caspases Mimetic with Toll-like Receptor 8 Agonist Reverses HIV-1-Latency and Enhances Antiviral ImmunityKillian E Vlaming, Jade Jansen, Godelieve J de Bree, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 8, 2020
[HIV vaccine: how far along are we?]Emma I M M Reiss, Marit J van Gils, Rogier W Sanders, et al.
Plos One|November 11, 2016
The Financial Burden of Non-Communicable Chronic Diseases in Rural Nigeria: Wealth and Gender Heterogeneity in Health Care Utilization and Health ExpendituresWendy Janssens, Jann Goedecke, Godelieve J de Bree, et al.
Pageof 11